Zhang Y, Xie M, Wen J, Liang C, et al. Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy. Gut 2024 Dec 12:gutjnl-2024-333154. doi: 10.1136/gutjnl-2024-333154.
PMID: 39667906